摘要
支气管哮喘是一种慢性炎症性气道疾病,以往认为辅助性T细胞1(Th1)/Th2比例失衡是哮喘发病的重要机制。近年发现了一种以产生IL—17为主要细胞因子的Th17细胞,在哮喘的发病机制中具有重要作用,IL-17还具有对哮喘的负性调节作用,有可能成为治疗哮喘的有意义的靶目标。
Bronchial asthma is a chronic inflammation airway disease. The imbalance of T helper cell (Th) 1/Th2 immunity plays an important role in the pathogenesis of allergic asthma. Recent years a new T cell lineage has been recognized as Th17 cells because they can produce cytokines interleukin-17. The new studies find that interleukin-17 is a negative regulator of asthma, and interleukin-17 or Th17 cells may represent an interesting therapeutic target in asthma.
出处
《国际儿科学杂志》
2011年第6期579-582,共4页
International Journal of Pediatrics